TY - JOUR
T1 - Effect of vagal nerve stimulation on systemic inflammation and cardiac autonomic function in patients with refractory epilepsy
AU - Barone, Lucy
AU - Colicchio, Gabriella
AU - Policicchio, Domenico
AU - Di Clemente, Francesca
AU - Di Monaco, Antonio
AU - Meglio, Mario
AU - Lanza, Gaetano A.
AU - Crea, Filippo
PY - 2007
Y1 - 2007
N2 - Objective: Recent data suggest that vagus nerve stimulation (VNS) can inhibit cytokine release by inflammatory cells. Accordingly, an association between impaired cardiac parasympathetic function, as assessed by heart rate variability (HRV), and increased markers of inflammation has recently been reported. In this study we assessed the effect of direct left VNS on inflammatory markers and HRV in patients with refractory epilepsy. Methods: A 24-hour electrocardiogram Holter recording was performed both at baseline and after 3 months of left VNS in 8 patients (age 32 ± 24 years, 2 men) who underwent implantation of a VNS device because of refractory epilepsy. Tumor necrosis factor-α, interleukin-6 and C-reactive protein serum levels were measured, as markers of inflammation, at the same times. Results: No significant changes were found after 3 months of left VNS, compared to baseline, both for HRV variables and inflammatory markers. Also, no consistent correlation could be demonstrated between HRV parameters and inflammatory markers in these patients. Conclusions: Our data in epileptic patients without cardiovascular disease failed to show a significant effect of left VNS on cardiac autonomic function and on systemic inflammation at short-term follow-up.
AB - Objective: Recent data suggest that vagus nerve stimulation (VNS) can inhibit cytokine release by inflammatory cells. Accordingly, an association between impaired cardiac parasympathetic function, as assessed by heart rate variability (HRV), and increased markers of inflammation has recently been reported. In this study we assessed the effect of direct left VNS on inflammatory markers and HRV in patients with refractory epilepsy. Methods: A 24-hour electrocardiogram Holter recording was performed both at baseline and after 3 months of left VNS in 8 patients (age 32 ± 24 years, 2 men) who underwent implantation of a VNS device because of refractory epilepsy. Tumor necrosis factor-α, interleukin-6 and C-reactive protein serum levels were measured, as markers of inflammation, at the same times. Results: No significant changes were found after 3 months of left VNS, compared to baseline, both for HRV variables and inflammatory markers. Also, no consistent correlation could be demonstrated between HRV parameters and inflammatory markers in these patients. Conclusions: Our data in epileptic patients without cardiovascular disease failed to show a significant effect of left VNS on cardiac autonomic function and on systemic inflammation at short-term follow-up.
KW - Cardiac autonomic tone
KW - Heart rate variability
KW - Inflammatory markers
KW - Left vagal stimulation
UR - http://www.scopus.com/inward/record.url?scp=44349133469&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=44349133469&partnerID=8YFLogxK
U2 - 10.1159/000127360
DO - 10.1159/000127360
M3 - Article
C2 - 18418007
AN - SCOPUS:44349133469
SN - 1021-7401
VL - 14
SP - 331
EP - 336
JO - NeuroImmunoModulation
JF - NeuroImmunoModulation
IS - 6
ER -